Evidence map›Paper›PMID 37921654›Full record

ArticleGlobal health action2023

Achieving the UNAIDS 95-95-95 treatment target by 2025 in Ghana: a myth or a reality?

Dorothy Serwaa Boakye, Samuel Adjorlolo

Open access · goldAbstract read
In one paragraph

Article in Global health action, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. HIV Stigma in Awi Zone, Northwest Ethiopia, and a Unique Community Association as a Potential Partner.International journal of environmental research and public health · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Dorothy Serwaa BoakyeDepartment of Health Administration and Education, University of Education, Winneba, Ghana.ORCID 0000-0002-6153-1273
Samuel AdjorloloSchool of Nursing and Midwifery, College of Health Sciences, University of Ghana, Legon, Ghana.ORCID 0000-0001-9308-6031
University of Ghana · GH

Funding

Addressing the Research Capacity Gap in Global Child and Adolescent Health Disparities Utilizing Implementation and Data Sciences among Vulnerable Populations in Resource-limited Settings (ACHIEVE)D43TW012275 · FIC · WASHINGTON UNIVERSITY · PI Theresa Stichick Betancourt, Mary McKernan McKay · 2022 to 2026
$7.2M
FIC NIH HHS D43 TW012275
6 · The paper itself

Abstract

The United Nations Joint Programme on HIV/AIDS (UNAIDS) has set ambitious treatment targets known as Project 95-95-95, aiming to achieve 95% of people living with HIV knowing their status, 95% of diagnosed individuals on antiretroviral therapy (ART), and 95% of those on ART achieving viral suppression by 2025. Through a comprehensive analysis of Ghana's HIV/AIDS response, we evaluate the feasibility of Ghana's efforts in realising these targets. The discussion explores Ghana's achievements in HIV testing and diagnosis, ART coverage, and viral suppression rates, as well as challenges related to stigma, limited access to healthcare services, funding constraints, and data quality. Strategies such as strengthening prevention efforts, expanding access to ART, addressing stigma, and enhancing health systems are discussed as the way forward to advance Ghana's progress towards the UNAIDS 95-95-95 treatment targets. While Ghana has made significant strides in its HIV/AIDS response, achieving the 95-95-95 targets is a challenging yet realistic goal.

Indexed as

Acquired Immunodeficiency SyndromeHIV InfectionsGhanaHumansUnited NationsachievementschallengesGhanaHIV/AIDS responseHIV testingtreatmentviral suppression

Identifiers

PMID37921654
PMCPMC10627043
OpenAlexW4388288961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.